The double triangular test in practice

Pharmaceutical Statistics

Volumn 3, Issue 1, 2004, Pages 39-49

  Whitehead, John ^a   Todd, Susan ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Clinical trial; Double triangular test; Group sequential design; Sequential design

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANESTHETIC AGENT; BRONCHODILATING AGENT; CARBAMAZEPINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DILTIAZEM; EPIRUBICIN; FIBRINOLYTIC AGENT; FLUOROURACIL; HYPNOTIC AGENT; LITHIUM DERIVATIVE; LITHIUM GAMOLENATE; PLACEBO; POLYMER; PROCHLORPERAZINE; REMACEMIDE; THIOTEPA; TRANQUILIZER; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECUBITUS; EPILEPSY; EVOLUTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; PANCREAS CANCER; PUBLISHING; REVIEW; SEQUENTIAL ANALYSIS; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS;

EID: 8844228436     PISSN: 15391604     EISSN: None     Source Type: Journal    
DOI: 10.1002/pst.91     Document Type: Review

References (42)

1. Whitehead J. The design and analysis of sequential clinical trials. Ellis Horwood: Chichester, 1983.
2. Whitehead J, Brunier H. The double triangular test: a sequential test for the two-sided alternative with early stopping under the null hypothesis. Sequential Analysis 1990; 9:117-136.
3. Whitehead J. The design and analysis of sequential clinical trials (revised 2nd edn). Wiley: Chichester, 1997.
4. Siegmund D. Estimation following sequential tests. Biometrika 1978; 65:341-349.
5. Stallard N, Facey KM. Comparison of the spending function method and the Christmas tree correction for group sequential trials. Journal of Biopharmaceutical Statistics 1996; 6:361-373.
6. Wald A. Sequential analysis. New York: Wiley, 1947.
7. Barnard GA. Sequential tests in industrial statistics. Journal of the Royal Statistical Society, Supplement 1946; 8 1-26.
8. Sobel M, Wald A. A sequential decision procedure for choosing one of three hypotheses concerning the unknown mean of a normal distribution. Annals of Mathematical Statistics 1949; 20 502-522.
9. Armitage P. Sequential medical trials. Oxford: Blackwell, 1960.
10. Armitage P. Sequential medical trials (2nd edn). Oxford: Blackwell, 1975.
11. Sainsbury P, Lucas CJ. Sequential methods applied to the study of prochlorperazine. British Medical Journal 1959; 2 737-740.
12. Jones NL. Clinical trials of a new aminophylline preparation. British Medical Journal 1963; 1: 1443-1445.
13. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chester E, DeMots H. Protective effects of aspirin against acute myocardinal infarction and death in men with unstable angina. New England Journal of Medicine 1983; 309:396-403.
14. Bross I. Sequential medical plans. Biometrics 1952; 8:188-205.
15. Newton DRL, Tanner JM. N-acetyl-para-aminophenol as an analgesic: A controlled clinical trial using the method of sequential analysis. British Medical Journal 1956; 2:1096-1099.
16. Thomson TJ. Clinical comparison of methyprylone and quinalbarbitone as hypnotics. British Medical Journal 1958; 2 1140-1141.
17. Parsons TW, Thomson TJ. Methaqualone as a hypnotic. British Medical Journal 1961; 171-173.
18. Parsons TW. Clinical comparison of barbiturates as hypnotics. British Medical Journal 1963; 2:1035-1037.
19. Kirwan JR, Haskard DO, Higgens CS. The use of sequential analysis to assess patient preference for local skin anaesthesia during knee aspiration. British Journal of Rheumatology 1984; 23 210-213.
20. Anderson TW. A modification of the sequential probability ratio test to reduce sample size. Annals of Mathematical Statistics 1960; 31:165-197.
21. Siegmund D. Corrected diffusion approximations in certain random walk problems. Advances in Applied Probability 1979; 11 701-719.
22. MPS Research Unit. PEST 4: Operating manual. University of Reading, 2000.
23. Pampallona S, Tsiatis AA. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favour of the null hypothesis. Journal of Statistical Planning and Inference 1994; 42:19-35.
24. Wang SK, Tsiatis AA. Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 1987; 43 193-199.
25. Cytel Software Corporation. EaSt 2000: A software package for the design and interim monitoring of group sequential clinical trials Cytel: Cambridge, MA, 2000:
26. Johnson CD, Puntis M, Davidson N, Todd S, Bryce R. Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma. British Journal of Surgery 2001; 88:662-668.
27. Brunier HC, Whitehead J. PEST 3.0: Operating manual. University of Reading, 1993.
28. Bergh J, Wiklund T, Erikstein B, Lidbrink E, Lindman H, Malmström P, Kellokumpu-Lehtinen P, Bengtsson N-O, Söderlund G, Anker G, Wist E, Ottosson S, Salminen E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Wilking N. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Lancet 2000; 356:1384-1391.
29. Boden WE, Scheldewaert R, Walters EG, Whitehead A, Coltart DJ, Santoni J-P, Belgrave G, Starkey IR. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first myocardial infarction. American Journal of Cardiology 1995; 75:1120-1123.
30. Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, Whitehead A, Bertrand ME, Col JJ, Pedersen OL, Lie KI, Santoni J-P, Fox KM. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Lancet 2000; 355:1751-1756.
31. Brodie MJ, Wroe SJ, Dean ADP, Holdich TAH, Whitehead J, Stevens JW. Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy and Behaviour 2002; 3:140-146.
32. Whitehead J. Monotherapy trials: sequential design. Epilepsy Research 2001; 45:81-87.
33. Beydoun A. Sequential design studies for antiepileptic drugs. Epilepsy and Behaviour 2002; 3:107-108.
34. French JA. Active-control antipileptic drug trials in the newly diagnosed patient: are we getting closer? Epilepsy and Behaviour 2002; 3:109-112.
35. Whitehead J, Stevens J, Brodie M, Wroe S, Dean A, Holdich T. Remacemide versus carbamazepine in newly diagnosed epilepsy (Letter to the Editor). Epilepsy and Behaviour 2002; 3:405-406.
36. Nixon J, McElvenny D, Mason S, Brown J, Bond S. A sequential randomised controlled trial comparing a dry visco-elastic polymer pad and standard operating table mattress in the prevention of post-operative pressure sores. International Journal of Nursing Studies 1998; 35:193-203.
37. Brown J, McElvenny D, Nixon J, Bainbridge J, Mason S. Some practical issues in the design, monitoring and analysis of a sequential randomised trial in pressure sore prevention. Statistics in Medicine 2000; 19:3389-3400.
38. Van der Tweel I, van Noord PAH. Sequential analysis of matched dichotomous data from prospective case-control studies. Statistics in Medicine 2000; 19:3449-3464.
39. Hedelin G. Sequential tests for conditional logistic regression and combination of 2 × 2 tables in case-control studies. Technical report, Laboratoire d'Épidémiologie et de Santé Publique, Université Louis Pasteur: Strasbourg, 1993.
40. Dreyfus M, Hedelin G, Kutnahorsky R, Lehmann M, Viville B, Langer B, Fleury A, M'Barek M, Treisser A, Wiesel M-L, Pasquali J-L. Antiphospholipid antibodies and preeclampsia: a casecontrol study. Obstetrics and Gynecology 2001; 97:29-34.
41. Whitehead J. Sequential designs for equivalence studies. Statistics in Medicine 1996; 15:2703-2715.
42. Whitehead J, Todd S, Hall WJ. Confidence intervals for secondary parameters following a sequential test. Journal of the Royal Statistical Society, Series B 2000; 62:731-745.